article · 2011
Evaluating the Characteristics and the Management of Patients With Neuroendocrine Tumors Receiving Octreotide LAR During a 6-Year Period
This retrospective study has added to the wealth of evidence demonstrating the efficacy and safety of octreotide LAR in the treatment of patients with NET. T...
44 citationsDOI: https://doi.org/10.1097/mpa.0b013e31821f66b4